Human Protein Argonaute-2 (AGO2) Protein

Este producto es parte de AGO - Protein Argonaute
Product Graph
234€ (2 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Protein Argonaute-2 (AGO2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx680535
tested applications
SDS-PAGE

Description

Human Protein Argonaute-2 (AGO2) Protein is a recombinant protein expressed in E. coli.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Protein Argonaute-2 (AGO2)
Host
E. coli
Origin
Human
Conjugation
Unconjugated
Observed MW
Molecular Weight: 98.4 kDa
Concentration: 0.46 mg/ml
Sequence Fragment: 1-859 AA
Tag: N-terminal His tag
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
2 µg
Size 2
10 µg
Size 3
1 mg
Form
Liquid 
Tested Applications
SDS-PAGE
Buffer
50 mM acetate buffer, pH 4.0, containing 20% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Store at 4 °C if the entire vial will be used within 2-4 weeks. Store at -20 °C for long term storage. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9UKV8
Gene ID
27161
OMIM
606229
Alias
CASC7,EIF2C2,LESKRES,LINC00980,PPD,Q10
Background
Protein AGO2
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

AGO2 is the most well-characterized and catalytically active member of the Argonaute family, playing a central role in the RISC complex. AGO2 binds miRNAs and small interfering RNAs (siRNAs) to mediate both translational repression and endonucleolytic cleavage (slicing) of target mRNAs. Its conserved PIWI domain is responsible for its slicer activity, enabling AGO2 to degrade complementary mRNA targets directly. AGO2 is highly expressed in many tissues and is involved in crucial cellular processes, including gene silencing, developmental regulation, and the cellular response to viral infections. Dysregulation of AGO2 contributes to various pathological conditions, including cancers, neurodegenerative diseases, and immune disorders, due to its impact on gene expression and miRNA/siRNA pathways. AGO2 is also being explored as a potential therapeutic target in RNA-based therapies.

Related Products

EH6174

Human AGO2 (Protein argonaute-2) ELISA Kit

Ver Producto
FNab00214

AGO2 antibody

This gene encodes a member of the Argonaute family of proteins which play a role in RNA interference. The encoded protein is highly basic, and contains a PAZ domain and a PIWI domain. It may interact with dicer1 and play a role in short-interfering-RNA-mediated gene silencing. Multiple transcript variants encoding different isoforms have been found for this gene.

Ver Producto
P2111

Recombinant Human AGO2

Ver Producto